Luca Baldini

Summary

Affiliation: Ospedale Maggiore
Country: Italy

Publications

  1. ncbi request reprint Prognostic validation of the international classification of immunoglobulin M gammopathies: a survival advantage for patients with immunoglobulin M monoclonal gammopathy of undetermined significance?
    Paolo G Gobbi
    Medicina Interna e Oncologia Medica and Laboratorio di Ricerche Biotecnologiche, Universita di Pavia, IRCCS Policlinico S Matteo, Piazzale Golgi no 2, 27100 Pavia, Italy
    Clin Cancer Res 11:1786-90. 2005
  2. doi request reprint Phase II fludarabine and cyclophosphamide for the treatment of indolent B cell non-follicular lymphomas: final results of the LL02 trial of the Gruppo Italiano per lo Studio dei Linfomi (GISL)
    Andrea Ferrario
    Unità Operativa Ematologia 1, Fondazione IRCCS, Ca Granda, Ospedale Maggiore Policlinico, Dipartimento Scienze Mediche, Universita degli Studi, Via F Sforza 35, Milan, Italy
    Ann Hematol 90:323-30. 2011
  3. ncbi request reprint Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenstrom's macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: proposal for a common prognostic scoring system
    Luca Baldini
    Unità Operativa Ematologia 1, Dipartimento di Ematologia e Oncologia, Ospedale Maggiore, I R C C S, Milano, Italy
    J Clin Oncol 23:4662-8. 2005
  4. ncbi request reprint Treatment of indolent B-Cell nonfollicular lymphomas: final results of the LL01 randomized trial of the Gruppo Italiano per lo Studio dei Linfomi
    Luca Baldini
    Unità Operativa Ematologia 1, Centro G Marcora, Ospedale Maggiore, IRCCS, Via F Sforza 35, 20121 Milano, Italy
    J Clin Oncol 21:1459-65. 2003
  5. doi request reprint The clinical and biological features of a series of immunophenotypic variant of B-CLL
    Lilla Cro
    UO Ematologia 1 CTMO, Universita degli Studi, Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, Milano, Italy
    Eur J Haematol 85:120-9. 2010
  6. doi request reprint A multicenter retrospective clinical study of CD5/CD10-negative chronic B cell leukemias
    Maria Goldaniga
    UO Ematologia e Centro Trapianti di Midollo, Ospedale Maggiore, IRCCS, University of Milan, Milan, Italy
    Am J Hematol 83:349-54. 2008
  7. doi request reprint The prognostic value of F-18 fluorodeoxyglucose bone marrow uptake in patients with recent diagnosis of multiple myeloma: a comparative study with Tc-99m sestamibi
    Massimo Castellani
    Department of Nuclear Medicine, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milan, Italy
    Clin Nucl Med 35:1-5. 2010
  8. ncbi request reprint B-cell nasal lymphoma mimicking hyperplastic chronic rhinitis
    Giovanna Cantarella
    Department of Otorhinolaryngology, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Via Francesco Sforza 35, 20122 Milan, Italy
    Otolaryngol Head Neck Surg 135:165-7. 2006
  9. doi request reprint Immune thrombocytopenia in patients with chronic lymphocytic leukemia is associated with stereotyped B-cell receptors
    Carlo Visco
    Department of Hematology, Ospedale San Bortolo, Vicenza, Milano, Italy
    Clin Cancer Res 18:1870-8. 2012
  10. doi request reprint CD26 expression in mature B-cell neoplasia: its possible role as a new prognostic marker in B-CLL
    Lilla Cro
    Fondazione Ospedale Maggiore Policlinico MaRe, IRCCS, Centro di Genetica Molecolare, UO Ematologia 1 CTMO, Laboratorio diagnostica onco ematologica, 20122Milan, Italy
    Hematol Oncol 27:140-7. 2009

Collaborators

Detail Information

Publications27

  1. ncbi request reprint Prognostic validation of the international classification of immunoglobulin M gammopathies: a survival advantage for patients with immunoglobulin M monoclonal gammopathy of undetermined significance?
    Paolo G Gobbi
    Medicina Interna e Oncologia Medica and Laboratorio di Ricerche Biotecnologiche, Universita di Pavia, IRCCS Policlinico S Matteo, Piazzale Golgi no 2, 27100 Pavia, Italy
    Clin Cancer Res 11:1786-90. 2005
    ..To verify the reliability of the new criteria for the diagnosis of IgM gammopathies recently proposed by an international panel of experts (Athens, 2002)...
  2. doi request reprint Phase II fludarabine and cyclophosphamide for the treatment of indolent B cell non-follicular lymphomas: final results of the LL02 trial of the Gruppo Italiano per lo Studio dei Linfomi (GISL)
    Andrea Ferrario
    Unità Operativa Ematologia 1, Fondazione IRCCS, Ca Granda, Ospedale Maggiore Policlinico, Dipartimento Scienze Mediche, Universita degli Studi, Via F Sforza 35, Milan, Italy
    Ann Hematol 90:323-30. 2011
    ..FC is effective for advanced untreated INFL. Early deaths and haematological toxicity suggest careful patient selection and monitoring...
  3. ncbi request reprint Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenstrom's macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: proposal for a common prognostic scoring system
    Luca Baldini
    Unità Operativa Ematologia 1, Dipartimento di Ematologia e Oncologia, Ospedale Maggiore, I R C C S, Milano, Italy
    J Clin Oncol 23:4662-8. 2005
    ....
  4. ncbi request reprint Treatment of indolent B-Cell nonfollicular lymphomas: final results of the LL01 randomized trial of the Gruppo Italiano per lo Studio dei Linfomi
    Luca Baldini
    Unità Operativa Ematologia 1, Centro G Marcora, Ospedale Maggiore, IRCCS, Via F Sforza 35, 20121 Milano, Italy
    J Clin Oncol 21:1459-65. 2003
    ..To evaluate the effect of epirubicin on therapeutic response and survival in patients with indolent nonfollicular B-cell lymphomas (INFL) treated with pulsed high-dose chlorambucil...
  5. doi request reprint The clinical and biological features of a series of immunophenotypic variant of B-CLL
    Lilla Cro
    UO Ematologia 1 CTMO, Universita degli Studi, Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, Milano, Italy
    Eur J Haematol 85:120-9. 2010
    ....
  6. doi request reprint A multicenter retrospective clinical study of CD5/CD10-negative chronic B cell leukemias
    Maria Goldaniga
    UO Ematologia e Centro Trapianti di Midollo, Ospedale Maggiore, IRCCS, University of Milan, Milan, Italy
    Am J Hematol 83:349-54. 2008
    ....
  7. doi request reprint The prognostic value of F-18 fluorodeoxyglucose bone marrow uptake in patients with recent diagnosis of multiple myeloma: a comparative study with Tc-99m sestamibi
    Massimo Castellani
    Department of Nuclear Medicine, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milan, Italy
    Clin Nucl Med 35:1-5. 2010
    ..We assessed the prognostic value of F-18 fluorodeoxyglucose (FDG) uptake in the bone marrow of patients with multiple myeloma (MM) in comparison with Tc-99m methoxy-isobutyl-isonitrile (MIBI)...
  8. ncbi request reprint B-cell nasal lymphoma mimicking hyperplastic chronic rhinitis
    Giovanna Cantarella
    Department of Otorhinolaryngology, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Via Francesco Sforza 35, 20122 Milan, Italy
    Otolaryngol Head Neck Surg 135:165-7. 2006
  9. doi request reprint Immune thrombocytopenia in patients with chronic lymphocytic leukemia is associated with stereotyped B-cell receptors
    Carlo Visco
    Department of Hematology, Ospedale San Bortolo, Vicenza, Milano, Italy
    Clin Cancer Res 18:1870-8. 2012
    ..To assess biologic features related to the development of immune thrombocytopenia (ITP) in patients with chronic lymphocytic leukemia (CLL)...
  10. doi request reprint CD26 expression in mature B-cell neoplasia: its possible role as a new prognostic marker in B-CLL
    Lilla Cro
    Fondazione Ospedale Maggiore Policlinico MaRe, IRCCS, Centro di Genetica Molecolare, UO Ematologia 1 CTMO, Laboratorio diagnostica onco ematologica, 20122Milan, Italy
    Hematol Oncol 27:140-7. 2009
    ....
  11. ncbi request reprint Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma
    Michela Mattioli
    Laboratorio di Ematologia Sperimentale e Genetica Molecolare and U O Ematologia 1, Dipartimento di Scienze Mediche, Universita degli Studi di Milano, Ospedale Maggiore IRCCS, Milano, Italy
    Oncogene 24:2461-73. 2005
    ....
  12. ncbi request reprint ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi
    Paolo G Gobbi
    Medicina Interna e Oncologia Medica, Universita di Pavia, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S Matteo, Pavia, Italy
    J Clin Oncol 23:9198-207. 2005
    ....
  13. ncbi request reprint Prognostic relevance of serum beta2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study
    Massimo Federico
    Dipartimento di Oncologia ed Ematologia, Centro Oncologico Modenese, Universita di Modena e Reggio Emilia, Policlinico, Via del Pozzo 71, 41100 Modena, Italy
    Haematologica 92:1482-8. 2007
    ..The present study examined the influence of beta2M levels on overall survival (OS) of patients with follicular lymphoma (FL)...
  14. ncbi request reprint High dose sequential chemotherapy with autologous transplantation versus dose-dense chemotherapy MegaCEOP as first line treatment in poor-prognosis diffuse large cell lymphoma: an "Intergruppo Italiano Linfomi" randomized trial
    Umberto Vitolo
    Ematologia, Azienda Ospedaliera S Giovanni Battista, Corso Bramante 88, 10126 Turin, Italy
    Haematologica 90:793-801. 2005
    ....
  15. ncbi request reprint Introduction of rituximab in front-line and salvage therapies has improved outcome of advanced-stage follicular lymphoma patients
    Stefano Sacchi
    Department of Oncology and Hematology, University of Modena, Modena, Italy
    Cancer 109:2077-82. 2007
    ....
  16. ncbi request reprint Splenic marginal zone lymphoma: a prognostic model for clinical use
    Luca Arcaini
    Division of Hematology, IRCCS Policlinico San Matteo, University of Pavia, 27100 Pavia, Italy
    Blood 107:4643-9. 2006
    ..In conclusion, with the use of readily available factors, this prognostic index may be an effective tool for evaluating the need for treatment and the intensity of therapy in an individual patient...
  17. ncbi request reprint Angiogenesis occurs in hairy cell leukaemia (HCL) and in NOD/SCID mice transplanted with the HCL line Bonna-12
    Giancarlo Pruneri
    Divisions of Pathology and Laboratory Medicine, University of Milan School of Medicine, Italy
    Br J Haematol 120:695-8. 2003
    ..The BM tumour burden significantly decreased in patients treated with interferon-alpha, but the mean value of MVD remained unchanged. These data suggest that angiogenesis may be involved in the pathogenesis of HCL...
  18. ncbi request reprint Epstein-Barr virus-associated lymphoma in Crohn's disease
    Alessandra Losco
    Postgraduate School of Gastroenterology, University of Milan, IRCCS Ospedale Maggiore and Ospedale S Paolo, Milan, Italy
    Inflamm Bowel Dis 10:425-9. 2004
    ..The identification of such cases may help to define the frequency of this association and how to manage the lymphoproliferative disorder...
  19. ncbi request reprint Prospective study of indolent non-follicular non-Hodgkin's lymphoma: validation of Gruppo Italiano per lo studio dei linfomi (GISL) prognostic criteria for watch and wait policy
    Fortunato Morabito
    Centro Trapianti di Midollo Osseo, Dipartimento di Ematologia, Azienda Ospedaliera Bianchi Melacrino Morelli Via Melacrino, 89100 Reggio Calabria, Italy
    Leuk Lymphoma 43:1933-8. 2002
    ..In conclusion, the GISL definition of indolent disease is a reliable tool to design the appropriate therapeutic strategy in this histological setting...
  20. ncbi request reprint Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue
    Emanuele Zucca
    Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland
    Blood 101:2489-95. 2003
    ..Our data confirm the indolent nature of nongastric MALT lymphomas and the high rate of patients presenting with disseminated disease, which, when limited to mucosal sites, was not associated with a poorer outcome...
  21. doi request reprint Immunoreactivity for cyclin D1 is a reliable marker of gene aberration in plasma cell myeloma but does not specify patients prognosis
    Giancarlo Pruneri
    Leuk Res 32:1628-32. 2008
  22. ncbi request reprint Cell cycle regulators in multiple myeloma: prognostic implications of p53 nuclear accumulation
    Giancarlo Pruneri
    Division of Pathology and Laboratory Medicine, European Institute of Oncology and University of Milan, School of Medicine, Italy
    Hum Pathol 34:41-7. 2003
    ..Our data suggest that the immunohistochemical evaluation of p53 IR in bone marrow biopsies may represent an adjunct in MM patient prognostication...
  23. ncbi request reprint Prognostic factors in symptomatic Waldenstrom's macroglobulinemia
    Giampaolo Merlini
    Research Biotechnology Laboratories, and Internal Medicine and Medical Oncology, IRCCS Policlinico San Matteo, Pavia, Italy
    Semin Oncol 30:211-5. 2003
    ..A prognostic index based on age, hemoglobin, and albumin is capable of identifying various groups of patients with different therapeutic needs...
  24. ncbi request reprint The length of treatment of aggressive non-Hodgkin's lymphomas established according to the international prognostic index score: long-term results of the GISL LA03 study
    Massimo Federico
    Dipartimento di Oncologia ed Ematologia, Universita di Modena e Reggio Emilia, Modena, Italy
    Eur J Haematol 76:217-29. 2006
    ..To compare two different schedules of two different anthracycline-containing regimens, where length of treatment is modulated according to the international prognostic index (IPI) in patients with aggressive non-Hodgkin's Lymphoma (NHL)...
  25. ncbi request reprint Prevalence and prognostic significance of sMUC-1 levels in plasma cell dyscrasias
    Stefano Luminari
    Dipartimento di Oncologia ed Ematologia, Universita di Modena e Reggio Emilia, Milan, Italy
    Br J Haematol 121:772-4. 2003
    ..49 months, P = 0.003)...
  26. ncbi request reprint Clinical and molecular complete remission in a case of variant hairy cell leukemia treated with DHAP followed by high-dose chemotherapy plus rituximab
    Maria Goldaniga
    Unità di Ematologia 1, Dipartimento di Ematologia ed Oncologia, Ospedale Maggiore IRCCS, Milan, Italy
    Haematologica 89:ECR41. 2004
  27. ncbi request reprint Microvessel density, a surrogate marker of angiogenesis, is significantly related to survival in multiple myeloma patients
    Giancarlo Pruneri
    Division of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan, School of Medicine, Italy
    Br J Haematol 118:817-20. 2002
    ..01), whereas there was no difference in survival between patients with low and high CD105+ MVD. Multivariate analysis confirmed the independent significant association between CD34+ MVD and survival (P = 0.001)...